Skip to content

Supporting Mothers’ Mental Health with Interpersonal Therapy

Evaluating the impact of group interpersonal psychotherapy compared to high-quality standard care for mothers with postnatal depression in Lebanon and Kenya on child developmental outcomes, maternal depression and the mother-child relationship

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
LBCTR
Registry ID
LBCTR2022024840
Enrollment
35
Registered
2022-05-23
Start date
2022-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maternal Depression - Child Development - Mother-Child Relationship PND

Interventions

g-IPT has proven to be an effective treatment for common mental health disorders, and one that can be used as a preventative intervention. The principle of g-IPT is that depression is triggered and wo
g-IPT

Sponsors

University College of London (UCL)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Kenya inclusion criteria: 1. Mothers who have recently given birth, living in one of the two research sites 2. Fathers who have recently had a child, living in one of the two research sites 3. Healthcare workers without mental health expertise, who work in one of the two research sites 4. Healthcare workers with mental health expertise, who work in one of the two research sites 5. Religious leaders working in one of the two research sites 6. Traditional midwives working in one of the two research sites 7. Key informants, such as staff working in local or national organisations in a related field (mental health, maternal health and early childhood health)

Exclusion criteria

Exclusion criteria: Participant exclusion criteria Feasibility trial: 1. Mothers with psychotic conditions including bipolar disorder, anorexia nervosa or substance dependency 2. Mothers whose babies have severe physical health problems or neurodevelopmental problems

Design outcomes

Primary

MeasureTime frame
Name: Severity of depression;Timepoints: baseline and at 8 (T2), 13 (T3), and 24 (T4) weeks post-treatment;Measure: Patient Health Questionnaire- depression module (PHQ-9)

Secondary

MeasureTime frame
Name: Family circumstances;Timepoints: baseline (T1) and 13 weeks (T3);Measure: family circumstances questionnaire;Name: Height and weight measures of infants ;Timepoints: baseline (T1) and 13 weeks (T3);Measure: following WHO guidelines;Name: Early childhood development outcomes ;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: Caregiver Reported Early Development Index (CREDI) long form;Name: Depression;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: Hamilton Depression Rating Scale (HRSD);Name: Anxiety;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: General Anxiety Disorder-7 (GAD-7);Name: Sleep;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: Sleep Condition Indicator (SCI);Name: Generic health status;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: Short-Form Health Survey (SF-36);Name: Infant’s sleep;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: Brief Infant Sleep Questionnaire – Revised Short form (BISQ);Name: Infant’s physical health;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: infant physical health questionnaire;Name: Infant’s cognitive development;Timepoints: 24 weeks (T4);Measure: Malawi Developmental Assessment Tool (MDAT);Name: Breastfeeding ;Timepoints: baseline (T1), 8 weeks (T2), 13 weeks (T3) and 24 weeks (T4);Measure: breastfeeding outcome measure;Name: Social isolation;Timepoints: baseline (T1) and 13 weeks (T3);Measure: Lubben Social Network Scale (LSNS-6) ;Name: Relationship satisfaction;Timepoints: baseline (T1) and 13 weeks (T3);Measure: Couple Satisfaction Index (CSI-16);Name: Health outcome;Timepoints: baseline (T1) and 13 weeks (T3);Measure: EQ-5D;Name: Capability;Timepoints: baseline (T1), 13 weeks (T3) and 24 weeks (T4);Measure: ICEpop CAPability measure for Adults (ICECAP-A);Name: Value of intervent

Countries

Kenya, Lebanon

Contacts

Public ContactPardi Maradian

NMHP-MoPH

pardi.maradian@nmhp-lb.com03-723070

Outcome results

None listed

Source: LBCTR (via WHO ICTRP) · Data processed: Feb 7, 2026